Pay in 4 interest-free payments of $10.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
is a potent and selective inhibitor of non-homologous end joining (NHEJ)
Smiles: N[C@@H](CC1C=CC=CC=1)C(=O)N1C/C(=C\C2=CC(Cl)=C(Cl)C=C2)/C(=O)/C(/C1)=C/C1=CC(Cl)=C(Cl)C=C1
PubMed Central PMCID: PMC4027795
The inhibitory activity of WZB117 on cancer cell growth is also confirmed with a clonogenic assay
ZLN005 - PGC-1α Transcriptional Activator. CAS# 49671-76-3 size:10mg solid is a potent and selectiveZLN005, CAS No. 49671 76 3, is a potent and selective small molecule PGC 1 transcriptional activator. It stimulates the expression of PGC 1 and downstream genes in skeletal muscle cells, improving glucose utilization and fatty acid oxidation. Chronic oral administration of ZLN005 at 15 mg kg per day to diabetic db db mice increased PGC 1 and downstream gene transcription in skeletal muscle, increasing fat oxidation and improving glucose tolerance,
US$ 450.00
US$ 525.00
US$ 78.00
US$ 35.00
US$ 925.00
US$ 157.50